Too quick to assume depression?
[Mar 3, 2009, 09:34], [BBC]
One in eight women are now being diagnosed with post natal depression. There is no doubt it can be a very challenging time for new mothers, but not everyone believes medicalising motherhood is the solution. Lorna's story suggests that if new mothers get the help they need, a medical diagnosis can often be avoided.
Number of drug addicts in Russia reaches 2.5 million
[Mar 2, 2009, 18:10], [RIA Novosti]
Up to 2.5 million Russians including 140,000 minors are addicted to illegal drugs, the head of the Federal Drug Control Service said on Tuesday. "The overall number of drug addicts in our country is between 2 and 2.5 million people between the ages of 18 and 39," Viktor Ivanov said. "There are more than 140,000 minors registered in rehabilitation centers who are suffering from drug addiction."
Watching TV no help to babies: study
[Mar 1, 2009, 23:54], 
The amount of time spent watching TV doesn't help or hinder brain development before the age of two, a study released Monday suggests. "Contrary to marketing claims and some parents' perception that television viewing is beneficial to children's brain development, no evidence of such benefit was found," said the study's lead author, Marie Evans Schmidt of Children's Hospital Boston.
Obama's cross-border prescription drug trade plans watched closely
[Feb 28, 2009, 22:05], [CBC]
U.S. President Barack Obama's $3.55-trillion (U.S.) budget that supports allowing people to buy cheaper medicines from Canada needs to be weighed in relation to his health-care reform plans, the head of a Canadian pharmacists group said Friday. On Thursday, Obama released his fiscal plan, which supports the U.S. Food and Drug Administration's "new efforts to allow Americans to buy safe and effective drugs from other countries."
Experimental drug helps MS patients walk better: study
[Feb 28, 2009, 17:49], [CBC]
An experimental drug seems to help some people with multiple sclerosis to walk better, which could improve their quality of life, researchers said. In this week's issue of the medical journal the Lancet, neurologist Dr. Andrew Goodman of the University of Rochester Medical Center and his colleagues reported the results of their trial comparing Acorda Therapeutics' drug fampridine with a placebo.